NO971417L - Nye estrener for indusering av hypotalmiske effekter - Google Patents

Nye estrener for indusering av hypotalmiske effekter

Info

Publication number
NO971417L
NO971417L NO971417A NO971417A NO971417L NO 971417 L NO971417 L NO 971417L NO 971417 A NO971417 A NO 971417A NO 971417 A NO971417 A NO 971417A NO 971417 L NO971417 L NO 971417L
Authority
NO
Norway
Prior art keywords
new esters
hypothalamic effects
inducing
inducing hypothalamic
steroids
Prior art date
Application number
NO971417A
Other languages
English (en)
Other versions
NO971417D0 (no
Inventor
David L Berliner
Nathan William Adams
Clive L Jennings-White
Original Assignee
Pherin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Corp filed Critical Pherin Corp
Publication of NO971417D0 publication Critical patent/NO971417D0/no
Publication of NO971417L publication Critical patent/NO971417L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0007—Androstane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår estren-steroider som binder seg til neuroepiteliske celler i det humane vomeronasale organet. Steroidene blir fortrinnsvis tilført i form av et famnasøytisk preparat inneholdende én eller flere farmasøytisk akseptable bærere. Figur 1 viser syntesen av 1, 3, 5 (10), 16- estratetraen-3-ol.
NO971417A 1994-09-29 1997-03-25 Nye estrener for indusering av hypotalmiske effekter NO971417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31605094A 1994-09-29 1994-09-29
PCT/US1995/012542 WO1996010032A1 (en) 1994-09-29 1995-09-29 Novel estrenes for inducing hypothalamic effects

Publications (2)

Publication Number Publication Date
NO971417D0 NO971417D0 (no) 1997-03-25
NO971417L true NO971417L (no) 1997-05-23

Family

ID=23227259

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971417A NO971417L (no) 1994-09-29 1997-03-25 Nye estrener for indusering av hypotalmiske effekter

Country Status (16)

Country Link
EP (2) EP0924219A3 (no)
JP (1) JPH10509423A (no)
KR (1) KR970706297A (no)
CN (1) CN1167489A (no)
AU (1) AU705422B2 (no)
BR (1) BR9509098A (no)
CA (1) CA2199044A1 (no)
CZ (1) CZ92697A3 (no)
FI (1) FI971315A0 (no)
HU (1) HUT76856A (no)
MX (1) MX9702253A (no)
NO (1) NO971417L (no)
NZ (1) NZ294510A (no)
PL (1) PL319601A1 (no)
RU (1) RU2160279C2 (no)
WO (1) WO1996010032A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US6331534B1 (en) 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
JP4450435B2 (ja) * 1996-07-23 2010-04-14 フィーリン・ファーマシューティカルズ・インコーポレイテッド Ｐｍｓおよび不安の症状を緩和する、ｖｎｏにおける神経化学刺激物質としてのステロイド
DE102007022916A1 (de) * 2007-05-14 2008-11-20 Henkel Ag & Co. Kgaa Pheromonhaltige kosmetische Mittel
CN111532108A (zh) * 2020-05-12 2020-08-14 中国科学院心理研究所 雌甾四烯的新用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984677A (en) * 1957-12-03 1961-05-16 Lasdon Foundation Inc Ethers of 1, 3, 5, 16-estratetraen-3-ol
US3264327A (en) * 1962-07-27 1966-08-02 Syntex Corp 17alpha-fluoro-, 17beta-chlorofluoroacetoxy- and 17beta-methyl-delta4-and delta5-androstene derivatives
JPS4956937A (no) * 1972-08-17 1974-06-03
DE3741801A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-methylen-estratriene
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
DE69333290T2 (de) * 1993-06-15 2004-09-09 Pherin Pharmaceuticals, Inc., Redwood City Estrensteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate

Also Published As

Publication number Publication date
EP0783513A4 (en) 2000-03-08
BR9509098A (pt) 1998-07-14
AU3733195A (en) 1996-04-19
EP0783513A1 (en) 1997-07-16
NO971417D0 (no) 1997-03-25
AU705422B2 (en) 1999-05-20
MX9702253A (es) 1997-06-28
CN1167489A (zh) 1997-12-10
RU2160279C2 (ru) 2000-12-10
FI971315A (fi) 1997-03-27
NZ294510A (en) 1999-04-29
WO1996010032A1 (en) 1996-04-04
EP0924219A3 (en) 2002-01-23
HUT76856A (en) 1997-12-29
EP0924219A2 (en) 1999-06-23
FI971315A0 (fi) 1997-03-27
CA2199044A1 (en) 1996-04-04
KR970706297A (ko) 1997-11-03
JPH10509423A (ja) 1998-09-14
CZ92697A3 (en) 1997-09-17
PL319601A1 (en) 1997-08-18

Similar Documents

Publication Publication Date Title
YU86001A (sh) Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
CA2245466A1 (en) Stanol ester composition and production thereof
DE59209907D1 (de) Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
IL123010A (en) Pharmaceutical compositions of l-dopa ethyl ester
NO971417L (no) Nye estrener for indusering av hypotalmiske effekter
ATE308327T1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
EA199800052A1 (ru) Новые норпрегнаны для стимуляции гипоталамических эффектов
MY111841A (en) Injectable liposomal pharmaceutical preparations
FI971536A (fi) Keratinosyytti-kasvutekijän analogeja
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
ATE237334T1 (de) Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer
NO955085L (no) Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
NO990498L (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
FI956028A0 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
ATE203665T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE69712055D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
DE69431662D1 (de) Stabilisierte tablettenformulierung
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
AR012341A1 (es) Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos
DE69429534T2 (de) Monoklonale antikörper gegen schaumzellen und ihre pharmazeutische und diagnostische anwendung
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application